UCS analysis provides illuminating insights into TP53 expression patterns across diverse histological subtypes, other patient conditions, and tumor stages, enriching our understanding of its involvement in uterine carcinosarcoma progression. Here, TP53 is linked to uterine carcinosarcoma.